Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Medicine|January 16, 2026
An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trialXiaoxu Li, Giorgia Benegiamo, Archana Vijayakumar, et al.
Hepatology (Baltimore, Md.)|May 13, 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDEkaterina Smirnova, Mark D Muthiah, Nicole Narayan, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitisArun J Sanyal, Quentin M Anstee, Michael Trauner, et al.
Journal of Hepatology|November 14, 2022
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scoresArun J Sanyal, Julie Foucquier, Zobair M Younossi, et al.
Hepatology (Baltimore, Md.)|November 10, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V Kowdley, et al.
Pageof 4